Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexvix Fluorescence vs White Light Cystoscopy for Bladder Cancer CIS
NCT00052637Phase 3Completed
- Sponsor
- Photocure
- Start
- Sep 2001
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hexaminolevulinate in bladder cancer, sponsored by Photocure. Started Sep 2001; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00052637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052637.